procainamide has been researched along with Thrombopenia in 10 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| " He subsequently developed new onset atrial fibrillation and was started on extended-release procainamide on hospital day 7." | 8.79 | Prolonged thrombocytopenia associated with procainamide in an elderly patient. ( Currie, MS; Hanlon, JT; Landrum, EM; Siegert, EA, 1994) |
| "An 81-year-old female developed marked thrombocytopenia associated with numerous megakaryocytes in the bone marrow, but without anemia or leukopenia, after taking procainamide (3 g/day) for a period of 2 months." | 7.67 | Procainamide-induced thrombocytopenia. ( Kosfeld, RE; Leight, L; Liu, YK; Rosenstein, R, 1984) |
| "Procainamide hydrochloride-induced thrombocytopenia has infrequently been reported in the past." | 7.67 | Thrombocytopenia following sustained-release procainamide. ( Carlson, RJ; Gottlieb, AJ; Meisner, DJ, 1985) |
| "Procainamide therapy has frequently been reported as a cause of agranulocytosis, but severe thrombocytopenia associated with the use of this drug has been noted only once." | 7.66 | Procainamide-induced agranulocytosis and thrombocytopenia. ( Amorosi, EL; Rothman, IK, 1979) |
| "A 70-year-old man, who had sustained ventricular tachycardias following a previous anterior myocardial infarction, suffered from skin eruptions and abnormal blood tests after 10 days following the oral administration of 1500 mg/day of procainamide." | 5.30 | [Procainamide-induced skin eruption associated with disseminated intravascular coagulation in a patient with sustained ventricular tachycardia]. ( Abe, H; Kohshi, K; Nakashima, Y; Numata, T; Yamamoto, O, 1999) |
| " He subsequently developed new onset atrial fibrillation and was started on extended-release procainamide on hospital day 7." | 4.79 | Prolonged thrombocytopenia associated with procainamide in an elderly patient. ( Currie, MS; Hanlon, JT; Landrum, EM; Siegert, EA, 1994) |
| "An 81-year-old female developed marked thrombocytopenia associated with numerous megakaryocytes in the bone marrow, but without anemia or leukopenia, after taking procainamide (3 g/day) for a period of 2 months." | 3.67 | Procainamide-induced thrombocytopenia. ( Kosfeld, RE; Leight, L; Liu, YK; Rosenstein, R, 1984) |
| "Procainamide hydrochloride-induced thrombocytopenia has infrequently been reported in the past." | 3.67 | Thrombocytopenia following sustained-release procainamide. ( Carlson, RJ; Gottlieb, AJ; Meisner, DJ, 1985) |
| "Procainamide therapy has frequently been reported as a cause of agranulocytosis, but severe thrombocytopenia associated with the use of this drug has been noted only once." | 3.66 | Procainamide-induced agranulocytosis and thrombocytopenia. ( Amorosi, EL; Rothman, IK, 1979) |
| "A 70-year-old man, who had sustained ventricular tachycardias following a previous anterior myocardial infarction, suffered from skin eruptions and abnormal blood tests after 10 days following the oral administration of 1500 mg/day of procainamide." | 1.30 | [Procainamide-induced skin eruption associated with disseminated intravascular coagulation in a patient with sustained ventricular tachycardia]. ( Abe, H; Kohshi, K; Nakashima, Y; Numata, T; Yamamoto, O, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hangaishi, A | 1 |
| Kurokawa, M | 1 |
| Rosenstein, R | 1 |
| Kosfeld, RE | 1 |
| Leight, L | 1 |
| Liu, YK | 1 |
| Christensen, DJ | 1 |
| Palma, LF | 1 |
| Phelps, K | 1 |
| Landrum, EM | 1 |
| Siegert, EA | 1 |
| Hanlon, JT | 1 |
| Currie, MS | 1 |
| Freeman, NJ | 1 |
| Fajardo, L | 1 |
| Carvalho, A | 1 |
| Numata, T | 1 |
| Abe, H | 1 |
| Nakashima, Y | 1 |
| Yamamoto, O | 1 |
| Kohshi, K | 1 |
| Wautier, JL | 1 |
| Rouger, P | 1 |
| Rothman, IK | 1 |
| Amorosi, EL | 1 |
| Meisner, DJ | 1 |
| Carlson, RJ | 1 |
| Gottlieb, AJ | 1 |
| McCormack, GD | 1 |
| Barth, WF | 1 |
3 reviews available for procainamide and Thrombopenia
| Article | Year |
|---|---|
[Drug-induced thrombocytopenia].
Topics: Abciximab; Antibodies, Monoclonal; Carbamazepine; Gold Compounds; Heparin; Humans; Immunoglobulin Fa | 2007 |
Prolonged thrombocytopenia associated with procainamide in an elderly patient.
Topics: Aged; Atrial Fibrillation; Delayed-Action Preparations; Humans; Male; Procainamide; Thrombocytopenia | 1994 |
[Drug-induced hemolytic anemia].
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents, Non-Steroidal; Antimetab | 2001 |
7 other studies available for procainamide and Thrombopenia
| Article | Year |
|---|---|
Procainamide-induced thrombocytopenia.
Topics: Aged; Female; Humans; Platelet Count; Prednisone; Procainamide; Thrombocytopenia | 1984 |
Agranulocytosis, thrombocytopenia, and procainamide.
Topics: Aged; Agranulocytosis; Delayed-Action Preparations; Female; Humans; Male; Procainamide; Thrombocytop | 1984 |
Simultaneous procainamide-induced immune thrombocytopenia and lupus anticoagulant.
Topics: Aged; Humans; Lupus Coagulation Inhibitor; Male; Procainamide; Thrombocytopenia | 1995 |
[Procainamide-induced skin eruption associated with disseminated intravascular coagulation in a patient with sustained ventricular tachycardia].
Topics: Aged; Anti-Arrhythmia Agents; Disseminated Intravascular Coagulation; Drug Eruptions; Humans; Male; | 1999 |
Procainamide-induced agranulocytosis and thrombocytopenia.
Topics: Aged; Agranulocytosis; Arteriosclerosis; Humans; Male; Procainamide; Thrombocytopenia | 1979 |
Thrombocytopenia following sustained-release procainamide.
Topics: Acecainide; Acetylation; Adult; Aged; Antibodies, Antinuclear; Delayed-Action Preparations; Humans; | 1985 |
Quinidine induced lupus syndrome.
Topics: Aged; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Procainamide; Quinidine; Thrombocyto | 1985 |